TipRanks
Advertisement
Advertisement

DRTS Stock Latest News

Alpha Tau signs MOU with Samsung Medical Center in Seoul
The FlyAlpha Tau signs MOU with Samsung Medical Center in Seoul
16h ago
DRTS
Alpha Tau Signs MOU with Samsung Medical Center for Pancreatic Cancer Trial in Korea
PremiumCompany Announcements
Alpha Tau Signs MOU with Samsung Medical Center for Pancreatic Cancer Trial in Korea
16h ago
6K
DRTS
Yi Chen Reiterates Buy on Alpha Tau as FDA-Backed Trial Expansion and Pivotal ReSTART Study Support Unchanged $16 Price Target
PremiumRatings
Yi Chen Reiterates Buy on Alpha Tau as FDA-Backed Trial Expansion and Pivotal ReSTART Study Support Unchanged $16 Price Target
3d ago
DRTS
Alpha Tau Wins FDA Nod to Expand U.S. REGAIN Glioblastoma Trial, Data Heading to SNO 2026
PremiumCompany Announcements
Alpha Tau Wins FDA Nod to Expand U.S. REGAIN Glioblastoma Trial, Data Heading to SNO 2026
4d ago
6K
DRTS
FDA Greenlights Expansion of Alpha Tau’s Brain Cancer Trial, With New Data Weeks Away (NASDAQ: DRTS)
PremiumTipRanks Newswire
FDA Greenlights Expansion of Alpha Tau’s Brain Cancer Trial, With New Data Weeks Away (NASDAQ: DRTS)
4d ago
DRTS
Alpha Tau announces FDA approval of REGAIN trial IDE supplement
PremiumThe FlyAlpha Tau announces FDA approval of REGAIN trial IDE supplement
4d ago
DRTS
Alpha Tau’s Cancer Trials Keep Beating Expectations. Three Major Data Readouts Are Next.
Premium
TipRanks Newswire
Alpha Tau’s Cancer Trials Keep Beating Expectations. Three Major Data Readouts Are Next.
1M ago
DRTS
Alpha Tau price target raised to $30 from $17 at Barclays
Premium
The Fly
Alpha Tau price target raised to $30 from $17 at Barclays
2M ago
DRTS
Alpha Tau Completes Enrollment in IMPACT Pancreatic Cancer Pilot Study of Alpha DaRT
PremiumCompany Announcements
Alpha Tau Completes Enrollment in IMPACT Pancreatic Cancer Pilot Study of Alpha DaRT
2M ago
6K
DRTS
Alpha Tau completes patient enrollment in IMPACT study
PremiumThe Fly
Alpha Tau completes patient enrollment in IMPACT study
2M ago
DRTS
Alpha Tau price target raised to $16 from $15 at H.C. Wainwright
PremiumThe Fly
Alpha Tau price target raised to $16 from $15 at H.C. Wainwright
2M ago
DRTS
Alpha Tau Medical Updates Investors With H1 2026 Financials in New Form 6-K Filing
PremiumCompany Announcements
Alpha Tau Medical Updates Investors With H1 2026 Financials in New Form 6-K Filing
2M ago
6K
DRTS
Alpha Tau reports Q2 EPS (25c), consensus (14c)
PremiumThe FlyAlpha Tau reports Q2 EPS (25c), consensus (14c)
2M ago
DRTS
Alpha Tau Medical Registers for Dual Listing on Tel Aviv Stock Exchange
Premium
Company Announcements
Alpha Tau Medical Registers for Dual Listing on Tel Aviv Stock Exchange
2M ago
6K
DRTS
Alpha Tau’s Cancer Combination Just Delivered a Response Rate More Than 5X Keytruda’s Historical Benchmark
Premium
TipRanks Newswire
Alpha Tau’s Cancer Combination Just Delivered a Response Rate More Than 5X Keytruda’s Historical Benchmark
3M ago
DRTS
Alpha Tau reports Alpha DaRT combination study results
PremiumThe Fly
Alpha Tau reports Alpha DaRT combination study results
3M ago
DRTS
Alpha Tau Posts Strong Alpha DaRT–Keytruda Data in Head and Neck Cancer Study
PremiumCompany Announcements
Alpha Tau Posts Strong Alpha DaRT–Keytruda Data in Head and Neck Cancer Study
3M ago
6K
DRTS
Alpha Tau treats first patient in ADMIRE study for recurrent skin cancer
PremiumThe Fly
Alpha Tau treats first patient in ADMIRE study for recurrent skin cancer
3M ago
DRTS
Largest borrow rate increases among liquid names
PremiumThe Fly
Largest borrow rate increases among liquid names
4M ago
BBD
IRE
Alpha Tau Medical Shareholders Back Board, CEO Dual Role and Auditor at June 2026 AGM
PremiumCompany AnnouncementsAlpha Tau Medical Shareholders Back Board, CEO Dual Role and Auditor at June 2026 AGM
4M ago
6K
DRTS
Alpha Tau Medical Continues Its Winning Streak with First-Ever Brain-Cancer Patient Treated Outside the U.S.
Premium
TipRanks Newswire
Alpha Tau Medical Continues Its Winning Streak with First-Ever Brain-Cancer Patient Treated Outside the U.S.
4M ago
DRTS
Alpha Tau Treats First Recurrent Glioblastoma Patient Outside U.S. With Alpha DaRT in Israel
Premium
Company Announcements
Alpha Tau Treats First Recurrent Glioblastoma Patient Outside U.S. With Alpha DaRT in Israel
4M ago
6K
DRTS

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >